It's an exciting time in #DLBCL. In this review published in ASCO Publications we highlight the improved genomic classifications of #DLBCL and the path forward for #PrecisionMedicine.

Great session! Nice work @Ore Odejide MD

Excited to present updates on D+V in R/R #CLL at #ASH20 with Matthew Davids, MD, MMSc and others: annualmeeting.hematology.org/posters/255784…

The Laboratory of Functional Precision Medicine and the Letai Lab are looking for a scientist with a Bachelor's degree to come help us change how drugs are chosen for cancer patients. Friends, please RT. Posting here careers.dana-farber.org/job/letai-lab-…

Sad we are not together in sunny California, but grateful for this amazing group at virtual #ASH #CRTI Matthew J. Maurer, ScD Martin S. Tallman, MD Adam Kittai Kate Lurain #MeganOthus #AlexHerrera

The future of CLL therapy has arrived: our ph2 AVO trial in 1L CLL from Dana-Farber and BIDMC with support from AstraZeneca and Genentech is now online The Lancet Oncology authors.elsevier.com/a/1dlF45EIIgEB…

Favorable real-world outcomes with CART in PMBCL. Grateful for the collaboration on this project.

#ASCO23: SWOG-S1826 paves the way for nivolumab+AVD as new standard of care for advanced-stage Hodgkin lymphoma: fal.cn/3yO3a #ASCODailyNews City of Hope Ann LaCasce, MD #lymsm

Agree!

So pleased to work with Jennifer Crombie, MD @falchi_Lorenzo and a great team of authors from around the world and from a variety of treatment settings on these recommendations for #bispecifics. Now available @bloodjournal #lymsm Lymphoma Research Foundation @lymphomaoz bit.ly/3SvFfhl

Remember to join us on 5/31 at 6:30 PM CDT for a PeerView #Lymphoma & #MultipleMyeloma live in-person & virtual symposium with Drs. Jagannath, Sabarish Ayyappan MD, & Jennifer Crombie, MD. Please tweet your questions in advance! bit.ly/T2024Bispecifi… #ASCO24 #Bispecifics #MedEd

Congratulations Society of Hematologic Oncology (SOHO) on such diversity in gender and geographic presentations at an excellent educational meeting #SOHO2024